PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE
The present invention comprises compounds of Formula (I). Wherein: R 1, R 2, R 3, R 4 and R 5 are defined in the specification, and methods of treating or ameliorating a syndrome, disorder or disease described herein by administration of a therapeutically effective amount of at least one compound of...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | CROS, Josep Llaveria BUYCK, Christophe FANG, Lichao VITURRO, Carlos Manuel Martinez MARTINEZ LAMENCA, Carolina |
description | The present invention comprises compounds of Formula (I). Wherein: R 1, R 2, R 3, R 4 and R 5 are defined in the specification, and methods of treating or ameliorating a syndrome, disorder or disease described herein by administration of a therapeutically effective amount of at least one compound of Formula (I). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4469454A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4469454A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4469454A13</originalsourceid><addsrcrecordid>eNrjZDANiAxyjPL38QfSnr6eLp5-rsEKjsEKvv4uoT6OIf5BwQr-bgrBAa5BvkApBf8ITxfHYFceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiYmZpYmriaGhMhBIA6Kkn3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE</title><source>esp@cenet</source><creator>CROS, Josep Llaveria ; BUYCK, Christophe ; FANG, Lichao ; VITURRO, Carlos Manuel Martinez ; MARTINEZ LAMENCA, Carolina</creator><creatorcontrib>CROS, Josep Llaveria ; BUYCK, Christophe ; FANG, Lichao ; VITURRO, Carlos Manuel Martinez ; MARTINEZ LAMENCA, Carolina</creatorcontrib><description>The present invention comprises compounds of Formula (I). Wherein: R 1, R 2, R 3, R 4 and R 5 are defined in the specification, and methods of treating or ameliorating a syndrome, disorder or disease described herein by administration of a therapeutically effective amount of at least one compound of Formula (I).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469454A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469454A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CROS, Josep Llaveria</creatorcontrib><creatorcontrib>BUYCK, Christophe</creatorcontrib><creatorcontrib>FANG, Lichao</creatorcontrib><creatorcontrib>VITURRO, Carlos Manuel Martinez</creatorcontrib><creatorcontrib>MARTINEZ LAMENCA, Carolina</creatorcontrib><title>PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE</title><description>The present invention comprises compounds of Formula (I). Wherein: R 1, R 2, R 3, R 4 and R 5 are defined in the specification, and methods of treating or ameliorating a syndrome, disorder or disease described herein by administration of a therapeutically effective amount of at least one compound of Formula (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANiAxyjPL38QfSnr6eLp5-rsEKjsEKvv4uoT6OIf5BwQr-bgrBAa5BvkApBf8ITxfHYFceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiYmZpYmriaGhMhBIA6Kkn3A</recordid><startdate>20241204</startdate><enddate>20241204</enddate><creator>CROS, Josep Llaveria</creator><creator>BUYCK, Christophe</creator><creator>FANG, Lichao</creator><creator>VITURRO, Carlos Manuel Martinez</creator><creator>MARTINEZ LAMENCA, Carolina</creator><scope>EVB</scope></search><sort><creationdate>20241204</creationdate><title>PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE</title><author>CROS, Josep Llaveria ; BUYCK, Christophe ; FANG, Lichao ; VITURRO, Carlos Manuel Martinez ; MARTINEZ LAMENCA, Carolina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4469454A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CROS, Josep Llaveria</creatorcontrib><creatorcontrib>BUYCK, Christophe</creatorcontrib><creatorcontrib>FANG, Lichao</creatorcontrib><creatorcontrib>VITURRO, Carlos Manuel Martinez</creatorcontrib><creatorcontrib>MARTINEZ LAMENCA, Carolina</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CROS, Josep Llaveria</au><au>BUYCK, Christophe</au><au>FANG, Lichao</au><au>VITURRO, Carlos Manuel Martinez</au><au>MARTINEZ LAMENCA, Carolina</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE</title><date>2024-12-04</date><risdate>2024</risdate><abstract>The present invention comprises compounds of Formula (I). Wherein: R 1, R 2, R 3, R 4 and R 5 are defined in the specification, and methods of treating or ameliorating a syndrome, disorder or disease described herein by administration of a therapeutically effective amount of at least one compound of Formula (I).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP4469454A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A21%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CROS,%20Josep%20Llaveria&rft.date=2024-12-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4469454A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |